$2.11
0.13[6.57%]
At close: Mar 25
$2.11
0[0.00%]
PreMarket: 4:03PM EDT
Trinity Biotech reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Trinity Biotech using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
04/09/2024 | AM | TRIB | Q4 | -$1.33 | -$0.70 | — | — | $18.04M | $15.00M | — | — | Get Alert |
01/31/2024 | AM | TRIB | Q3 | -$1.18 | -$0.75 | -$0.88 | -17.33% | $19.50M | $14.50M | $14.68M | 1.22% | Get Alert |
10/03/2023 | AM | TRIB | Q2 | -$1.45 | -$0.45 | -$0.80 | -77.78% | $18.46M | $13.50M | $13.90M | 2.95% | Get Alert |
07/06/2023 | AM | TRIB | Q1 | -$2.50 | -$0.30 | -$0.76 | -153.33% | $15.68M | $18.50M | $14.83M | -19.84% | Get Alert |
03/23/2023 | AM | TRIB | Q4 | -$0.30 | — | -$1.33 | — | $19.52M | $18.00M | $18.04M | 0.20% | Get Alert |
12/15/2022 | AM | TRIB | Q3 | $0.44 | — | -$1.18 | — | $22.00M | — | $19.50M | — | Get Alert |
11/03/2022 | AM | TRIB | Q2 | $1.00 | — | -$1.45 | — | $25.84M | — | $18.46M | — | Get Alert |
06/30/2022 | AM | TRIB | Q1 | $0.51 | -$0.20 | -$0.40 | -100.00% | $25.59M | $20.00M | $18.78M | -6.12% | Get Alert |
04/11/2022 | AM | TRIB | Q4 | $1.80 | — | -$0.02 | — | $32.77M | — | $19.52M | — | Get Alert |
12/15/2021 | PM | TRIB | Q3 | $1.80 | — | $0.44 | — | $32.01M | $26.00M | $22.00M | -15.37% | Get Alert |
09/09/2021 | AM | TRIB | Q2 | $0.05 | $0.35 | $1.00 | 185.71% | $16.02M | $25.00M | $25.84M | 3.37% | Get Alert |
05/25/2021 | AM | TRIB | Q1 | $0.05 | $0.35 | $0.51 | 45.71% | $21.18M | $24.00M | $25.59M | 6.64% | Get Alert |
03/25/2021 | AM | TRIB | Q4 | $0.45 | $0.70 | $1.80 | 157.14% | $21.32M | $28.00M | $32.77M | 17.02% | Get Alert |
11/17/2020 | AM | TRIB | Q3 | $0.22 | — | $1.80 | — | $24.59M | $21.18M | $32.01M | 51.15% | Get Alert |
08/25/2020 | AM | TRIB | Q2 | -$0.01 | $0.00 | $0.05 | — | $22.50M | $21.18M | $16.02M | -24.34% | Get Alert |
05/27/2020 | AM | TRIB | Q1 | $0.20 | — | $0.27 | — | $22.03M | $22.50M | $21.18M | -5.88% | Get Alert |
03/31/2020 | AM | TRIB | Q4 | $0.35 | — | $0.45 | — | $24.52M | $24.50M | $21.32M | -12.99% | Get Alert |
10/16/2019 | AM | TRIB | Q3 | $0.26 | — | $0.22 | — | $23.71M | — | $24.59M | — | Get Alert |
08/20/2019 | AM | TRIB | Q2 | $0.34 | $0.00 | -$0.01 | — | $25.00M | $24.00M | $22.50M | -6.26% | Get Alert |
Trinity Biotech (TRIB) is scheduled to report earnings on April 9, 2024. The last reported earnings were for reported on January 31, 2024 for Q3.
The Actual EPS was $-0.88, which missed the estimate of $-0.75.
The Actual Revenue was $14.7M, which beat the estimate of $14.5M.
Browse earnings estimates, EPS, and revenue on all stocks.